HKEX: 2162 - Keymed Biosciences Inc.

Yield per half year: +10.17%
Dividend yield: 0.00%
Sector: Healthcare

Current price
35.2 HK$
Average price
56.04 HK$ +59.21%
Price based on EPS
58.83 HK$ +67.14%
Discount price Net Income
53.25 HK$ +51.27%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 58.83 HK$
Current price = 35.2 HK$ (difference = +67.14%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -85.43 HK$
Current price = 35.2 HK$ (difference = -342.71%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -58.66 HK$
Current price = 35.2 HK$ (difference = -266.64%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe